drugset / Trial / NCT00185354

FC Patch Comparator Study

NCT00185354

Phase 3 Completed 422 enrolled Bayer
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to compare bleeding pattern and safety of contraceptive patch SH P00331F to a marketed comparator.

Timeline

Start
2004-11
Primary completion
2006-04
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Gestodene Small molecule 1.9 mg Other
Subject ethinyl estradiol Small molecule 0.6 mg Other
Subject ethinyl estradiol Small molecule 0.9 mg Other
Comparator norelgestromin Unknown 6 mg Other

Indications

No indication recorded.